27th Congress of the International Society on Thrombosis and Hemostasis

by N. V. Seredavkina
Published 2020-03-01

OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS

by N V Seredavkina, Tatyana Magomedaliyevna Reshetnyak
Published 2009-12-01

The place of intravenous immunoglobulin in rheumatic diseases

by N. V. Seredavkina, T. M. Reshetnyak, E. L. Nasonov
Published 2016-01-01

ACTOVEGIN IN THE COMPLEX THERAPY OF VASCULAR DISORDERS IN ANTIPHOSPHOLIPID SYNDROME

by N V Seredavkina, D V Burenchev, T M Reshetnyak
Published 2010-06-01

ACTOVEGIN IN THE COMPLEX THERAPY OF VASCULAR DISORDERS IN ANTIPHOSPHOLIPID SYNDROME

by N V Seredavkina, D V Burenchev, T M Reshetnyak
Published 2010-06-01

GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS

by N. V. Seredavkina, A. V. Smirnov, I. S. Dydykina, T. M. Reshetnyak
Published 2014-11-01

GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS

by T. M. Reshetnyak, N. V. Seredavkina, I. S. Dydykina, E. I. Nasonov
Published 2014-07-01

GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS

by N. V. Seredavkina, A. V. Smirnov, I. S. Dydykina, T. M. Reshetnyak
Published 2014-11-01

GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS

by T. M. Reshetnyak, N. V. Seredavkina, I. S. Dydykina, E. I. Nasonov
Published 2014-07-01

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antip...

by N. V. Seredavkina, T. M. Reshetnyak, N. M. Kosheleva, A. M. Lila
Published 2019-03-01

Risk factors for venous thromboses in patients with rheumatoid arthritis

by M. A. Satybaldyeva, T. M. Reshetnyak, N. V. Seredavkina, S. I. Glukhova, E. L. Nasonov
Published 2019-01-01

Aspergillosis in systemic lupus erythematosus

by T. M. Reshetnyak, S. G. Radenska-Lopovok, K. V. Makarov, N. V. Seredavkina, E. L. Nasonov
Published 2016-05-01

15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014)

by N. V. Seredavkina, L. N. Denisov, T. V. Korotaeva, L. V. Kondratyeva, M. V. Podryadnova
Published 2015-03-01

Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome

by N V Seredavkina, T M Reshetnyak, D V Burenchev, L V Kondratyeva, E L Nasonov
Published 2008-06-01

15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014)

by N. V. Seredavkina, L. N. Denisov, T. V. Korotaeva, L. V. Kondratyeva, M. V. Podryadnova
Published 2015-01-01

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology

by N V Seredavkina, T M Reshetnyak, E N Alexandrova, A A Novikov, E S Mach, T V Popkova
Published 2009-08-01

VALIDATION OF A RUSSIAN-LANGUAGE VERSION OF THE VEINES-QOL/SYM QUESTIONNAIRE IN PATIENTS WITH RHEUMATIC DISEASES AND LOWER EXTREMITY CHRONIC VENOUS DISEASES

by M. A. Satybaldyeva, N. V. Seredavkina, S. I. Glukhova, I. N. Gorskikh, T. M. Reshetnyak, E. L. Nasonov
Published 2017-10-01

Risk factors for venous thromboembolic events in patients with rheumatoid arthritis

by M. A. Satybaldyeva, T. M. Reshetnyak, N. V. Seredavkina, S. I. Glukhova, D. E. Karateev, E. L. Nasonov
Published 2016-10-01

Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range

by N V Seredavkina, T M Reshetnyak, M A Satybaldyeva, L N Kashnikova, T A Temnikova, E L Nasonov
Published 2019-05-01

GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM

by E. V. Ostryakova, N. L. Patrusheva, A. P. Aleksankin, L. I. Patrushev, N. V. Seredavkina, E. N. Aleksandrova, A. V. Volkov, T. M. Reshetnyak
Published 2011-06-01